Journal
MEDICINA-LITHUANIA
Volume 58, Issue 2, Pages -Publisher
MDPI
DOI: 10.3390/medicina58020223
Keywords
enterocutaneous fistula; self-expanding metal stents; gastrointestinal surgery
Categories
Ask authors/readers for more resources
Enterocutaneous fistula is an abnormal connection between the gastrointestinal tract and the skin, usually a complication of gastrointestinal surgery. The use of self-expanding metal stents (SEMS) to cover the fistula is a treatment method, but its application in small bowel ECF is still debated.
Enterocutaneous fistula (ECF) is an abnormal connection between the gastrointestinal tract and the skin; by some estimates, it represents 88.2% of all fistulae. It can either develop spontaneously due to underlying malignancy, inflammatory bowel disease, radiation exposure, or, more commonly, as a complication of gastrointestinal surgery. A 75-year-old woman was treated for a small bowel enterocutaneous fistula that developed after laparoscopic cholecystectomy using a HANAROSTENT self-expanding metal stent (SEMS) to cover the fistula. Seven months later, the patient was discharged. For the following 2 years, the patient refused the reconstructive surgery until stent obstruction occurred. After optimizing the patient's nutritional status, laparotomy and small bowel resection were performed successfully. The use of SEMS in fistulas of the lower gastrointestinal tract is a heavily debated and fairly under-researched topic, especially in the context of enterocutaneous fistulas. No international guidelines officially recommend using SEMS in the small bowel ECF.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available